---
schema_version: "secwatch.filing_event.v1"
accession: "0001006837-25-000134"
form_type: "8-K"
ticker: "VATE"
cik: "0001006837"
company_name: "INNOVATE Corp."
filed_at: "2025-12-16T23:59:59+00:00"
generated_at: "2026-05-16T12:59:35.787959+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# INNOVATE's MediBeacon receives FDA approval for next-gen TGFR System

## Summary
- MediBeacon (44.7%-owned by VATE) gets FDA nod for TGFR System with reusable sensor.
- Reusable sensor lowers cost vs prior single-use version; designed for patient comfort.
- Initial sales at select US and China academic medical centers expected Q1 2026.
- TGFR System featured as lead article in Journal of the American Society of Nephrology August 2025.
- Transdermal GFR assessment does not require age, weight, sex, race, or ethnicity inputs.

## SEC filing metadata
- accession: 0001006837-25-000134
- form_type: 8-K
- ticker: VATE
- cik: 0001006837
- company_name: INNOVATE Corp.
- filed_at: 2025-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/0001006837-25-000134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006837/000100683725000134/hchc-20251216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001006837-25-000134
- JSON: https://secwatch.observer/filing/0001006837-25-000134.json
- Plain text: https://secwatch.observer/filing/0001006837-25-000134.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.